Poly (ADP-ribose) polymerase inhibition: past, present and future

NJ Curtin, C Szabo - Nature Reviews Drug Discovery, 2020 - nature.com
The process of poly (ADP-ribosyl) ation and the major enzyme that catalyses this reaction,
poly (ADP-ribose) polymerase 1 (PARP1), were discovered more than 50 years ago. Since …

Endothelial dysfunction and diabetic cardiomyopathy

M Wang, Y Li, S Li, J Lv - Frontiers in Endocrinology, 2022 - frontiersin.org
The cardiovascular complications contribute to a majority of diabetes associated morbidity
and mortality, accounting for 44% of death in those patients with type 1 diabetes mellitus …

Nanoenzyme-reinforced injectable hydrogel for healing diabetic wounds infected with multidrug resistant bacteria

S Wang, H Zheng, L Zhou, F Cheng, Z Liu, H Zhang… - Nano …, 2020 - ACS Publications
Diabetic wound healing remains a critical challenge due to its vulnerability to multidrug-
resistant (MDR) bacterial infection, as well as the hyperglycemic and oxidative wound …

Antioxidant effects and mechanisms of medicinal plants and their bioactive compounds for the prevention and treatment of type 2 diabetes: an updated review

JO Unuofin, SL Lebelo - Oxidative medicine and cellular …, 2020 - Wiley Online Library
Diabetes mellitus is a metabolic disorder that majorly affects the endocrine gland, and it is
symbolized by hyperglycemia and glucose intolerance owing to deficient insulin secretory …

Diabetic microvascular disease: an endocrine society scientific statement

EJ Barrett, Z Liu, M Khamaisi, GL King… - The Journal of …, 2017 - academic.oup.com
Both type 1 and type 2 diabetes adversely affect the microvasculature in multiple organs.
Our understanding of the genesis of this injury and of potential interventions to prevent, limit …

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

X Wu, M Xu, M Geng, S Chen, PJ Little, S Xu… - Signal transduction and …, 2023 - nature.com
The ever-increasing prevalence of noncommunicable diseases (NCDs) represents a major
public health burden worldwide. The most common form of NCD is metabolic diseases …

PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection

MT Tran, ZK Zsengeller, AH Berg, EV Khankin… - Nature, 2016 - nature.com
The energetic burden of continuously concentrating solutes against gradients along the
tubule may render the kidney especially vulnerable to ischaemia. Acute kidney injury (AKI) …

[HTML][HTML] Endothelial dysfunction—a major mediator of diabetic vascular disease

CM Sena, AM Pereira, R Seiça - … et Biophysica Acta (BBA)-molecular basis …, 2013 - Elsevier
The vascular endothelium is a multifunctional organ and is critically involved in modulating
vascular tone and structure. Endothelial cells produce a wide range of factors that also …

Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy

M Knapp, X Tu, R Wu - Acta Pharmacologica Sinica, 2019 - nature.com
Diabetes mellitus is currently a major public health problem. A common complication of
diabetes is cardiac dysfunction, which is recognized as a microvascular disease that leads …

[HTML][HTML] Vascular complications of diabetes: mechanisms of injury and protective factors

C Rask-Madsen, GL King - Cell metabolism, 2013 - cell.com
In patients with diabetes, atherosclerosis is the main reason for impaired life expectancy,
and diabetic nephropathy and retinopathy are the largest contributors to end-stage renal …